“…Several studies have demonstrated the immunostimulatory and therapeutic success of CpG oligodeoxynucleotides (ODNs) application in various host–pathogen interaction models [ 18 , 19 , 20 ]. The protection provided by CpG ODNs against lethal challenges of extracellular bacteria, such as Escherichia coli [ 18 ] and Salmonella Typhimurium [ 19 ], and viruses, such as low pathogenic avian influenza virus [ 20 ] and infectious laryngotracheitis virus (ILTV) [ 21 , 22 ], in chickens have been well documented. CpG ODNs are known to induce an array of cytokines; chemokines; and effecter molecules, such as interferon (IFN) α, β and γ, interleukin (IL)-1β, IL-6, IL-12, IL-8, tumor necrosis factor (TNF)-α, and nitric oxide (NO) [ 23 , 24 , 25 ].…”